HDAC9 and cancer: Additionally, resveratrol as an HDAC inhibitor can induce cancer cell cycle arrest, differentiation, and death, reduce angiogenesis, and modulate the immune response, thus opening up new perspectives for its clinical use as a chemopreventive drug or cancer therapeutic [11,12].